Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Nitric BioTherapeutics, Inc |
---|---|
Information provided by: | Nitric BioTherapeutics, Inc |
ClinicalTrials.gov Identifier: | NCT00790608 |
The purpose of the study is to determine if topically applied nitric oxide gas is effective in reducing the quantity of bacteria (including MRSA)in a wound.
Condition | Intervention | Phase |
---|---|---|
Skin Ulcers Methicillin-Resistant Staphylococcus Aureus Infection |
Drug: Nitric Oxide |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase II Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus in MRSA Positive Ulcers |
Estimated Enrollment: | 20 |
Study Start Date: | January 2009 |
Estimated Study Completion Date: | May 2009 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Nicola Ivins | + 44 (0) 2920746319 | ivinsnm@Cardiff.ac.uk |
United Kingdom | |
Department of Wound Healing, Cardiff University | |
Cardiff, United Kingdom, CF14 4XN |
Principal Investigator: | Keith Harding, MB ChB, MRGCP, FRCS | Department of Wound Healing, Cardiff University |
Responsible Party: | Nitric BioTherapeutics ( Tanya Rhodes/Chief Technology Officer ) |
Study ID Numbers: | CTP 5, EudraCT 2008-001287-36 |
Study First Received: | November 12, 2008 |
Last Updated: | December 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00790608 |
Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Nitric Oxide Bacterial Infections Staphylococcal Infections Gram-Positive Bacterial Infections |
Methicillin Skin Diseases Ulcer Skin Ulcer |
Anti-Infective Agents Respiratory System Agents Vasodilator Agents Neurotransmitter Agents Antioxidants Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Anti-Asthmatic Agents Cardiovascular Agents Infection |
Protective Agents Pharmacologic Actions Anti-Bacterial Agents Pathologic Processes Autonomic Agents Therapeutic Uses Free Radical Scavengers Endothelium-Dependent Relaxing Factors Peripheral Nervous System Agents Bronchodilator Agents |